← Leaderboards
Nolan Wages
Virginia Commonwealth University
$2,368,536
Attributed
$2,368,536
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $339.1K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,368,536 · 4
By mechanism
R01$1,006,038 · 1
K25$779,790 · 1
P01$421,208 · 1
R03$161,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Joshua (chuck) Harrell$3,090,169
- Guizhi Zhu$6,644,378
- Devanand Sarkar$13,330,601
- Kenneth Seedman Kendler$36,426,058
- Brien P Riley$7,350,297
Others in their field
Top investigators on “Methodology”
- Jeffrey P Krischer · University Of South Florida$292,633,089
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- George R Seage · Abt Associates, Inc.$220,948,872
- Peter B. Gilbert · Fred Hutchinson Cancer Center$210,957,667
- Daniel Ernest Ford · Johns Hopkins University$158,461,124
Research focus
MethodologyDesignInnovationClinical TrialsPhase I Clinical TrialsSafetyDoseDrug DevelopmentMaximum Tolerated DoseBaseProbabilityNovel TherapeuticsSoftware DevelopmentToxic EffectPatient-Focused OutcomesPhase I TrialAlgorithmsOncologyLaboratoriesFormulationFacultyImmunotherapyConsultationsAnticancer Research
Grant awards (13)
Biostatistics and Bioinformatics Core (BBC)$210,604
P01 · FY2025 · CA · contact PI
Biostatistics and Bioinformatics Core (BBC)$210,604
P01 · FY2024 · CA · contact PI
Dose finding designs for late-onset toxicities$328,462
R01 · FY2023 · CA · contact PI
Dose finding designs for late-onset toxicities$257,915
R01 · FY2022 · CA · contact PI
Dose finding designs for late-onset toxicities$80,601
R01 · FY2022 · CA · contact PI
Dose finding designs for late-onset toxicities$339,060
R01 · FY2021 · CA · contact PI
Dose-finding designs for adoptive cell therapy trials$80,750
R03 · FY2020 · CA · contact PI
Dose-finding designs for adoptive cell therapy trials$80,750
R03 · FY2019 · CA · contact PI
Phase I Designs for Combined Immunotherapies in Cancer$155,958
K25 · FY2018 · CA · contact PI
Phase I Designs for Combined Immunotherapies in Cancer$155,958
K25 · FY2017 · CA · contact PI
Phase I Designs for Combined Immunotherapies in Cancer$155,958
K25 · FY2016 · CA · contact PI
Phase I Designs for Combined Immunotherapies in Cancer$155,958
K25 · FY2015 · CA · contact PI
Phase I Designs for Combined Immunotherapies in Cancer$155,958
K25 · FY2014 · CA · contact PI